Cost-Effectiveness of Levetiracetam for Patients With Juvenile Myoclonic Epilepsy: A Modeling Approach By The Brazilian Public Health Care System Perspective

Abstract

received DMT. Patients with DMT were less likely to have a corticosteroid claim than patients not receiving DMT (39% vs 62%), and less likely to have an ER visit (39% vs 54%) or hospitalization episode (18% vs 29%).